You just read:

Asterias Biotherapeutics Reports Third Quarter Results and Accelerating Enrollment of AST-OPC1 SCiStar Phase 1/2a Study

News provided by

Asterias Biotherapeutics, Inc.

Nov 14, 2016, 16:01 ET